Monsanto Co. (NYSE:MON) updated its FY17 earnings guidance on Wednesday. The company provided earnings per share guidance of $4.50-4.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.92.
A number of research analysts have recently issued reports on the company. Deutsche Bank AG reaffirmed a buy rating on shares of Monsanto in a research note on Thursday. Barclays PLC reaffirmed a hold rating and set a $110.00 price objective on shares of Monsanto in a research note on Thursday. Monness Crespi & Hardt reduced their price objective on Monsanto from $130.00 to $128.00 and set a buy rating on the stock in a research note on Monday. Goldman Sachs Group Inc. raised Monsanto from a sell rating to a neutral rating and set a $104.00 price objective on the stock in a research note on Tuesday, September 27th. Finally, Sanford C. Bernstein raised Monsanto from an underperform rating to a market perform rating and raised their price objective for the company from $82.81 to $105.00 in a research note on Monday, September 26th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of Buy and a consensus price target of $114.67.
Shares of Monsanto Co. (NYSE:MON) opened at 103.50 on Friday. Monsanto Co. has a 12 month low of $83.73 and a 12 month high of $114.26. The company has a market cap of $45.29 billion, a P/E ratio of 45.55 and a beta of 1.19. The company’s 50 day moving average is $104.88 and its 200 day moving average is $101.34.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. The firm’s revenue was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.19) earnings per share. On average, equities research analysts predict that Monsanto Co. will post $4.89 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be given a dividend of $0.54 per share. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 annualized dividend and a yield of 2.09%. Monsanto’s dividend payout ratio is presently 89.26%.
In related news, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares in the company, valued at $2,196,501.91. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total transaction of $2,899,287.60. Following the sale, the chief operating officer now owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. Corporate insiders own 0.88% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the stock. FMR LLC raised its stake in Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock valued at $1,715,960,000 after buying an additional 4,851,499 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock valued at $1,540,185,000 after buying an additional 38,316 shares in the last quarter. Capital International Investors raised its stake in Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock valued at $846,690,000 after buying an additional 476,848 shares in the last quarter. TIAA CREF Investment Management LLC raised its stake in Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock valued at $481,732,000 after buying an additional 1,560,646 shares in the last quarter. Finally, Third Point LLC purchased a new stake in Monsanto during the second quarter valued at approximately $206,820,000. Institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.